Krystal Biotech Inc (KRYS)

170.85 -5.54 (-3.14%) USD  |  NASDAQ  |  Nov 04, 16:00
171.06 +0.21 (+0.12%) After-Hours: 20:00
More

Krystal Biotech Asset Impairment Charge (Quarterly)

Asset Impairment Charge (Quarterly) Chart

View Asset Impairment Charge (Quarterly) for KRYS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Asset Impairment Charge (Quarterly) Data

View and export this data back to . Upgrade now.
Date Value

Asset Impairment Charge Definition

Asset Impairment Charge is a part of the consolidated statement of cash flows, specifically cash flows from operations. Asset impairment charges occur when the market value of a company's asset decreases below its book value. This process is called a writedown.

Read full definition.

Asset Impairment Charge (Quarterly) Range, Past 5 Years

--
Minimum
--
Maximum
--
Average
--
Median

Asset Impairment Charge (Quarterly) Benchmarks

Bioventus Inc Upgrade
ADMA Biologics Inc --
Axsome Therapeutics Inc --
Amicus Therapeutics Inc --
Sarepta Therapeutics Inc --